InsidersTradesSigma
申报总数
公司
▲ 买入（5 笔）
▼ 卖出（0 笔）
内部人交易记录
其他已披露买入
5
已披露卖出
0
尚无足够的、已确定 T+90 期限的买入信号来衡量交易记录。
信号历史
Explore the complete record of transactions filed by Coats Lonnel. Officer active across 2 companies, notably Blueprint Medicines Corp. Cumulatively, 15 disclosures have been recorded. Split: 5 buys · 0 sell. Total volume traded: €224k. Activity tracked since 2 June 2021. The latest transaction was disclosed on 18 June 2025 (Attribution). Regulator: SEC (Form 4). All data is free.
Companies and markets linked to Coats Lonnel
Open company profiles for insider transactions, fundamentals and analyst consensus when available.
申报15 总计
6,144 股Common StockSEC:0001104659-25-069392:0
3,902 股@ US$12,812.0098.9% 占其流量Common StockSEC:0001415889-25-018069:0
7,500 股@ US$69.791.1% 占其流量Common StockSEC:0001415889-24-027545:0
2,242 股0Common StockSEC:0001415889-24-016985:0
33,333 股Common StockSEC:0001127602-24-007612:0
90,000 股@ US$1.053339.0% 占其流量Common StockSEC:0001127602-23-027850:0
标准退出：2024年2月14日 (T+90)
10,000 股@ US$1.014.2% 占其流量Common StockSEC:0001127602-23-027279:0
标准退出：2024年2月8日 (T+90)
10,000 股@ US$2.168.9% 占其流量Common StockSEC:0001127602-23-019560:0
标准退出：2023年9月27日 (T+90)
10,000 股@ US$2.49510.2% 占其流量Common StockSEC:0001127602-23-019405:0
标准退出：2023年9月21日 (T+90)
2,600 股0Common StockSEC:0001415889-23-010259:0
40,000 股@ US$2.3137.7% 占其流量Common StockSEC:0001127602-23-019231:0
标准退出：2023年9月20日 (T+90)
84,630 股Common StockSEC:0001127602-23-007915:0
2,600 股0Common StockSEC:0001415889-22-007133:0
79,380 股Common StockSEC:0001127602-22-007167:0
2,250 股0Common StockSEC:0001179110-21-006419:0
15 条申报中的 15 条
About Coats Lonnel
COATS LONNEL is a declarant linked to Lexicon Pharmaceuticals, INC. as Chief Executive Officer and to Blueprint Medicines Corp as Director. He has 15 filings in total, and across the 15 sampled filings between 2021-06-04 and 2025-07-21, buys total 223758 EUR and sells 0 EUR, with transaction nature indicated as Attribution.
